Tag: licensing
-
Merck Inks Three Covid-19 Vaccine, Therapy Deals
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections.
-
Depression Therapy Licensed for Online Distribution
A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use.
-
Start-Up Gains Hydrogen Fuel Technology Funds
A spin-off company from a university engineering lab received funds to build a device that efficiently splits water and creates hydrogen for fuel cell cars.
-
Venture Producing Covid-19 Antibody Test Kits
A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies.
-
Antibody Neutralizes Covid-19, SARS Viruses
An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections.
-
Pharmas License A.I.-Aided Gene Therapies
A university spin-off company designing synthetic viruses with artificial intelligence to deliver gene therapies is licensing its work for eye and muscle disorders.
-
Stem Cell Therapy Licensed for Genetic Eye Disease
A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million.
-
![[Updated] Fast Paper Strip Covid-19 Test Devised with Crispr](https://technewslit.com/sciencebusiness/wp-content/uploads/2019/03/SherlockTestStrips_Zhanglab_BroadInst-150x112.jpg)
[Updated] Fast Paper Strip Covid-19 Test Devised with Crispr
A simple, fast test for Covid-19 infections with treated paper dipped in specimens is being created with the gene-editing technology Crispr.
-
A.I.-Aided Method Predicts Glaucoma Progression
Clinical trial results show a technique visualizing cells in the retina and analyzed with an algorithm accurately predicts the progression of glaucoma.
-
Oxford, AstraZeneca Partner on Covid-19 Vaccine
AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford.